Earum Pharmaceuticals Ltd
Earum Pharmaceuticals (BSE)

3.21

19.80
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for Earum Pharmaceuticals Ltd stands at 3 against 3, three months back.

Earum Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in marketing, trading and distribution of range of pharmaceutical formulation products, such as antibiotic drugs, antimalarial drugs, anti-allergic and anti-cold drugs, analgesic/anti-pyretic and anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants and injections. It offers a range of pharmaceutical formulation products, of which around 120 products are marketed by the Company under its own brand name. The Company also deals in the trading of active pharmaceutical ingredients (API’s). It carries out distribution of a range of its business operations in domestic and international markets.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
4.93
100 DMA ()
5.80
200 DMA ()
10.35
52 Weeks Range
3.21
26.40
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity